Biocept (BIOC) Reports Q2 Loss of $0.38/sh

Biocept (NASDAQ: BIOC) reported Q2 EPS of ($0.38), versus ($0.05) reported last year. Revenue for the quarter came in at $1.2 million, versus $917.5 thousand reported last year.

For earnings history and earnings-related data on Biocept (BIOC) click here.

You May Also Be Interested In

• Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
• BWS Financial Starts Capstone Energy Plus (CEPL) at Buy
• Nio gains after Goldman ups stock to Buy on strong growth, compelling valuation